色播婷婷电影综合社区,AV女优不卡亚洲在线,99999AV,日韩人妻中文字幕视频,国产拍自偷,91人人妻,超碰在线81,免费福利视频一区,九草青草原在线看

Zhejiang Lvchuang Biotechnology Co., Ltd. is a high-tech enterprise integrating technology development, technical consultation, technology transfer, and technical services in the fields of biology, pharmaceuticals, and pharmaceutical intermediates, as well as the processing and sales of pharmaceutical intermediates and food additives.

The company was established in May 2015 and is located in Deqing County, Huzhou City, Zhejiang Province. It enjoys convenient transportation and a superior geographical location, with Shanghai to the east, Hangzhou to the south, Taihu Lake to the north, and the Tianmu Mountain foothills to the west. The company's production and R&D base is situated in the Zhejiang Huzhou Moganshan High-Tech Industrial Development Zone. It covers a total area of 3,000 square meters and employs over 30 staff members, including 2 professors, 5 doctors, and 5 senior engineers. Most employees come from key technical and production positions of listed companies, bringing extensive R&D and industrial experience. Within two years, the company has successfully developed and industrialized more than 10 products, transferred 9 technology projects, and provided contract manufacturing services for 20 varieties to 15 organizations. It holds 23 patents.

The factory is equipped with standard laboratories and production workshops. The laboratories include fermentation, extraction, and synthesis labs, featuring advanced fermentation, synthesis, extraction, formulation, and testing instruments and equipment. The company has established a GB/T 19001-2016/ISO 9001:2015 quality management system and obtained certification.

Leveraging modern biotechnology, the company focuses on enzyme-catalyzed alternatives for synthetic drug processes, strain improvement for bulk fermentation drugs, optimization of fermentation and extraction processes, and the development and scale-up of biopharmaceutical production. These efforts aim to enhance production standards and product quality in the biopharmaceutical industry while reducing costs. Currently, with a rich product line and outstanding R&D capabilities as core strengths, combined with global marketing expertise, the company is transitioning from an R&D-focused to an R&D-and-production-balanced enterprise. It is rapidly advancing toward its goal of becoming a modern, international, and sustainable company!